XML 70 R44.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Commitments, Contingent Liabilities and Litigation (Narrative) (Details) $ in Millions | 3 Months Ended | 6 Months Ended |
--- | --- | --- | ---
Dec. 31, 2015 USD ($) | Dec. 31, 2015 USD ($) | Dec. 31, 2014 USD ($) | Jun. 30, 2015 USD ($)
Loss Contingencies |  |  |  |
Proceeds from Legal Settlements | $ 13.0 | $ 13.0 |  |
Commitments [Abstract] |  |  |  |
Payments to Acquire Businesses, Net of Cash Acquired |  | 3,284.0 | $ 86.0 |
DEA Investigation and Related Matters |  |  |  |
Loss Contingencies |  |  |  |
Litigation accrual | $ 44.0 | $ 44.0 |  | $ 41.0
CVS Health |  |  |  |
Commitments [Abstract] |  |  |  |
Initial term of Pharmaceutical Sourcing Venture |  | 10 years |  |
Number of quarterly payments |  | 39 |  |
Quarterly payment |  | $ 25.6 |  |
Increase in quarterly payments |  | 10.0 |  |
Fiscal 2017 | CVS Health |  |  |  |
Commitments [Abstract] |  |  |  |
Further Increase in Quarterly Payments |  | 10.0 |  |
Maximum Quarterly Payment |  | $ 45.6 |  |

X
- Definition Further Increase in Quarterly Payments for pharmaceutical sourcing venture if certain milestones are achieved. + References No definition available. + Details
Name: | cah_FurtherIncreaseinQuarterlyPayments
Namespace Prefix: | cah_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Increase in Quarterly Payments for pharmaceutical sourcing venture due to the achievement of a milestone. + References No definition available. + Details
Name: | cah_IncreaseinQuarterlyPayments
Namespace Prefix: | cah_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Initial term of Pharmaceutical Sourcing Venture + References No definition available. + Details
Name: | cah_InitialtermofPharmaceuticalSourcingVenture
Namespace Prefix: | cah_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Maximum Quarterly Payment for pharmaceutical sourcing venture if certain milestones are achieved. + References No definition available. + Details
Name: | cah_MaximumQuarterlyPayment
Namespace Prefix: | cah_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number Of Quarterly Payments related to pharmaceutical sourcing venture. + References No definition available. + Details
Name: | cah_NumberOfQuarterlyPayments
Namespace Prefix: | cah_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Quarterly payment that we are required to pay related to the pharmaceutical sourcing venture. + References No definition available. + Details
Name: | cah_QuarterlyPayments
Namespace Prefix: | cah_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_LitigationReserve
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OtherCommitmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Cash received for the settlement of litigation during the current period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585 + Details
Name: | us-gaap_ProceedsFromLegalSettlements
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_LitigationCaseAxis=cah_DEAInvestigationandRelatedMattersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MajorCustomersAxis=cah_CVSHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=cah_OneYearAfterCurrentFiscalYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |